Finally, no significant differences in leukemic cell counts, complete remission, genotype, gender, age, AML type, or karyotype were observed between AML patients with high TβRII–B expression and patients with low TβRII-B expression. The gene discussed is TGFBR2; the disease is acute myeloid leukemia.